HA155

CAS No. 1312201-00-5

HA155( CS-963 )

Catalog No. M26244 CAS No. 1312201-00-5

HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 335 Get Quote
10MG 494 Get Quote
25MG 782 Get Quote
50MG 1053 Get Quote
100MG 1422 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    HA155
  • Note
    Research use only, not for human use.
  • Brief Description
    HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.
  • Description
    HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.(In Vitro):HA155 completely attenuates the thrombin-mediated increase in platelet-derived LPA dose-dependently .HA155 is an ATX inhibitor by binding to the ATX active site .
  • In Vitro
    HA-155 inhibits ATX by binding to the ATX active site.HA155 completely attenuates the thrombin-mediated increase in platelet-derived LPA in a dose-dependent manner.
  • In Vivo
    ——
  • Synonyms
    CS-963
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1312201-00-5
  • Formula Weight
    463.29
  • Molecular Formula
    C24H19BFNO5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (21.58 mM)
  • SMILES
    O=C1N(CC2=CC=C(F)C=C2)C(S/C1=C\C3=CC=C(OCC4=CC=C(B(O)O)C=C4)C=C3)=O.[(Z)]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Guo B, et al. Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis. Clin Ther. 2017 Jul;39(7):1336-1346.
molnova catalog
related products
  • GSK 356278

    A potent, selective, brain-penetrant and orally bioavailable phosphodiesterase 4 (PDE4) inhibitor with pIC50 of 8.8 (PDE4B); equally inhibits PDE4A and PDE4Dwith pIC50 of 8.6 and 8.7.

  • Sildenafil

    Sildenfail is a vasoactive agent used to treat erectile dysfunction and reduce symptoms in patients with pulmonary arterial hypertension (PAH).

  • AMG-579

    AMG-579 is a potent, selective, CNS penetrant, orally bioavailable PDE10A inhibitor with IC50 of 0.1 nM.